Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice
文献类型:期刊论文
作者 | Ning, Bing-Bing2; Zhang, Yong1; Wu, Dan-Dan2; Cui, Jin-Gang2; Liu, Li2; Wang, Pei-Wei2; Wang, Wen-Jian2; Zhu, Wei-Liang1![]() |
刊名 | ACTA PHARMACOLOGICA SINICA
![]() |
出版日期 | 2017-03 |
卷号 | 38期号:3页码:331-341 |
关键词 | luteolin-7-diglucuronide ISO myocardial injury myocardial fibrosis NADPH oxidase collagen genes microRNAs TGF beta |
ISSN号 | 1671-4083 |
DOI | 10.1038/aps.2016.142 |
文献子类 | Article |
英文摘要 | Myocardial injury and ensuing fibrotic alterations impair normal heart architecture and cause cardiac dysfunction. Oxidative stress has been recognized as a key player in the pathogenesis of cardiac injury and progression of cardiac dysfunction, and promoting fibrosis. In the current study we investigated whether luteolin-7-diglucuronide (L7DG), a naturally occurring antioxidant found in edible plants, could attenuate isoproterenol (ISO)-induced myocardial injury and fibrosis in mice and the underlying mechanisms. Myocardial injury and fibrosis were induced in mice via injection of ISO (5 mg . kg(-1) u d(-1), ip) for 5 or 10 d. Two treatment regimens (pretreatment and posttreatment) were employed to administer L7DG (5-40 mg . kg(-1) . d(-1), ip) into the mice. After the mice were euthanized, morphological examinations of heart sections revealed that both L7DG pretreatment and posttreatment regimens significantly attenuated ISOinduced myocardial injury and fibrosis. But the pretreatment regimen caused better protection against ISO-induced myocardial fibrosis than the posttreatment regimen. Furthermore, L7DG pretreatment blocked ISO-stimulated expression of the genes (Cyba, Cybb, Ncf1, Ncf4 and Rac2) encoding the enzymatic subunits of NADPH oxidase, which was the primary source of oxidant production in mammalian cells. Moreover, L7DG pretreatment significantly suppressed ISO-stimulated expression of collagen genes Col1a1, Col1a2, Col3a1, and Col12a1 and non-collagen extracellular matrix genes fibrillin-1, elastin, collagen triple helix repeat containing 1 and connective tissue growth factor. In addition, L7DG pretreatment almost reversed ISO-altered expression of microRNAs that were crosstalking with TGF beta-mediated fibrosis, including miR-29c-3p, miR-29c-5p, miR-30c-3p, miR-30c-5p and miR-21. The current study demonstrated for the first time that L7DG is pharmacologically effective in protecting the heart against developing ISO-induced injury and fibrosis, justifying further evaluation of L7DG as a cardioprotective agent to treat related cardiovascular diseases. |
WOS关键词 | CARDIAC MAGNETIC-RESONANCE ; EXTRACELLULAR-MATRIX ; OXIDATIVE STRESS ; INFARCTION ; MICRORNAS ; BETA ; NECROSIS ; HEART ; CARDIOMYOPATHY ; PROLIFERATION |
资助项目 | Program of Eastern Scholar at Shanghai Institutions of Higher Learning[00000000] ; Shu Guang Project - Shanghai Municipal Education Commission[13SG42] ; National Natural Science Foundation of China[81273960] ; National Natural Science Foundation of China[81473732] |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
CSCD记录号 | CSCD:5936498 |
WOS记录号 | WOS:000395792800004 |
出版者 | ACTA PHARMACOLOGICA SINICA |
源URL | [http://119.78.100.183/handle/2S10ELR8/272758] ![]() |
专题 | 药物发现与设计中心 |
通讯作者 | Chen, Yu; Zhang, Teng |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Clin Res Inst Integrat Med, Shanghai 200437, Peoples R China; |
推荐引用方式 GB/T 7714 | Ning, Bing-Bing,Zhang, Yong,Wu, Dan-Dan,et al. Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice[J]. ACTA PHARMACOLOGICA SINICA,2017,38(3):331-341. |
APA | Ning, Bing-Bing.,Zhang, Yong.,Wu, Dan-Dan.,Cui, Jin-Gang.,Liu, Li.,...&Zhang, Teng.(2017).Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice.ACTA PHARMACOLOGICA SINICA,38(3),331-341. |
MLA | Ning, Bing-Bing,et al."Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice".ACTA PHARMACOLOGICA SINICA 38.3(2017):331-341. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。